3 ASX Stocks That Could Be Trading Up To 41.6% Below Intrinsic Value Estimates

Simply Wall St

As the Australian market remains rangebound, with the S&P/ASX 200 index hovering around the 8,500-point mark and showing little sign of a Santa Rally on the horizon, investors are closely monitoring economic indicators like bond yields and CPI data. In such an environment, identifying undervalued stocks becomes crucial for those looking to capitalize on potential discrepancies between market prices and intrinsic value estimates.

Top 10 Undervalued Stocks Based On Cash Flows In Australia

NameCurrent PriceFair Value (Est)Discount (Est)
Telix Pharmaceuticals (ASX:TLX)A$14.45A$25.2342.7%
Superloop (ASX:SLC)A$2.68A$5.3650%
Smart Parking (ASX:SPZ)A$1.315A$2.2641.9%
SenSen Networks (ASX:SNS)A$0.098A$0.1948%
LGI (ASX:LGI)A$4.18A$7.7546.1%
Guzman y Gomez (ASX:GYG)A$22.22A$39.4443.7%
Genesis Minerals (ASX:GMD)A$6.55A$13.0249.7%
Elders (ASX:ELD)A$7.16A$12.5643%
Cromwell Property Group (ASX:CMW)A$0.475A$0.8644.5%
Airtasker (ASX:ART)A$0.355A$0.6847.4%

Click here to see the full list of 36 stocks from our Undervalued ASX Stocks Based On Cash Flows screener.

Let's review some notable picks from our screened stocks.

Infomedia (ASX:IFM)

Overview: Infomedia Ltd, with a market cap of A$639.58 million, is a technology company that develops and supplies electronic parts catalogues, service quoting software, and e-commerce solutions for the global automotive industry.

Operations: The company's revenue is primarily derived from its publishing segment, specifically periodicals, which generated A$146.51 million.

Estimated Discount To Fair Value: 21.2%

Infomedia's recent acquisition by TPG Growth Capital Asia Limited for A$650 million highlights its undervaluation based on cash flows, as it was trading at A$1.70 per share, below the estimated fair value of A$2.15. Despite being dropped from several indices, Infomedia's earnings are forecast to grow significantly at 20% annually, surpassing the market average. The company's strong cash flow potential is further underscored by a special dividend announcement following the acquisition completion.

ASX:IFM Discounted Cash Flow as at Dec 2025

Immutep (ASX:IMM)

Overview: Immutep Limited is a biotechnology company focused on developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia, with a market cap of A$412.14 million.

Operations: The company generates revenue of A$5.03 million from its immunotherapy segment.

Estimated Discount To Fair Value: 41.6%

Immutep Limited appears undervalued based on cash flows, trading at A$0.28, significantly below its estimated fair value of A$0.48. Despite current unprofitability, it is expected to achieve profitability within three years with revenue forecasted to grow over 100% annually, outpacing the market's growth rate. Recent clinical trials in oncology have shown promising results for their lead product eftilagimod alfa (efti), enhancing its strategic position and potential future revenues in the immunotherapy sector.

ASX:IMM Discounted Cash Flow as at Dec 2025

Nickel Industries (ASX:NIC)

Overview: Nickel Industries Limited is involved in nickel ore mining and the production of nickel pig iron, cobalt, and nickel matte, with a market cap of A$3.08 billion.

Operations: The company's revenue segments include $120.89 million from nickel ore mining in Indonesia, $109.25 million from HPAL projects in Indonesia and Hong Kong, and $1.50 billion from RKEF projects in Indonesia and Singapore.

Estimated Discount To Fair Value: 37.6%

Nickel Industries is trading at A$0.71, approximately 37.6% below its estimated fair value of A$1.14, highlighting its undervaluation based on cash flows. The company recently completed an US$800 million bond issuance with a 9% coupon to extend debt maturity and repurchase higher-interest notes, strengthening financial flexibility. While revenue growth is expected at 13.1% annually—faster than the Australian market—profitability is anticipated within three years, offering potential for enhanced investor returns.

ASX:NIC Discounted Cash Flow as at Dec 2025

Where To Now?

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Infomedia might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com